Ron Bentsur Nuvectis Pharma, Inc. (NVCT) insider trading activity
Ron Bentsur is Chairman & CEO of Nuvectis Pharma, Inc.. Currently has a direct ownership of 3.52 Million shares of NVCT, which is worth approximately $24.4 Million. The most recent transaction as insider was on May 31, 2023, when has been sold 330 shares (Common Stock) at a price of $17.28 per share, resulting in proceeds of $5,702. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.52M
7.79%
3M change
8.75%
12M change
Total Value Held
$24.4 Million
RON BENTSUR Transaction History
Also insider at
RB
Ron Bentsur
Chairman & CEO
Garden City, NY